Pattern of Admission of Children With COVID-19 Admitted in Assuit University Children Hospital.
NCT ID: NCT05940155
Last Updated: 2023-07-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
30 participants
OBSERVATIONAL
2022-04-01
2023-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Implementation of case definition depend on the clinical presentation of the case and on laboratory test as well asradiological finding.The cases will be stratified according to these collective data to different grades of severity.
Mild cases are either asymptomatic or symptomatic with Leucopenia and/or lymphopenia with no radiological evidence of pneumonia (upper respiratory tract illness ± one of the following symptoms: fever \< 38, cough,GIT symptoms, myalgia and/or arthralgia).
Moderate cases include patients with leucopenia and/or lymphopenia with clinical and radiological evidence of pneumonia, including fever \> 38 °Cwith or without cough and tachypnea (respiratory rate \> 60 breaths/min forinfants \< 2 months, \> 50 breaths/min for infants 2-12 months, \> 40 breaths/min for children 1-4 years, \> 30 breaths/min for children older than5 years old), and the condition may be associated by moderate to severe dehydration.
Cases are considered as severe and critically ill if any of the following is present: - O2 saturation ≤ 92% despite escalating O2 therapy to maximal allowed 6 L/min - O2 saturation ≤ 90 % at room air - If the patient in septic shock, confused or hemodynamically unstable despite fluid resuscitation - If respiratory manifestations are combined with other organ failure - Chest radiography \> 50% lesion or progressive lesion within 24-48 hrs.
Children may play a major role in community-based viral transmission. Available data suggest that children may have more upper respiratory tract involvement (including nasopharyngeal carriage) rather than lower respiratory tract involvement.
The decision of the site of management either at home or in hospital depends on the clinical presentation, requirement for supportive care, potential risk factors for severe disease, and the ability of the patient to self-isolate at home. Supportive treatment including sufficient fluid and calories intake, and additional oxygen supplementation should be used in the treatment of children infected with COVID-19. The aim is to prevent ARDS, organ failure, and secondary nosocomial infections. If bacterial infection is suspected, broad-spectrum antibiotics may be used.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study on Children With COVID-19 Admitted at Assiut University Children Hospital
NCT05421247
COVID-19 IN CHILDREN IN NIGER, 2020
NCT05886179
Incidence of Covid-19 in School Children
NCT04377737
Non-malarial Febrile Illness in Children in Areas of Perennial Malaria Transmission
NCT01043744
Household-level Impact of IPT of Malaria in Schoolchildren
NCT04660110
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
mild cases
No interventions assigned to this group
moderate cases
RT PCR test of COVID 19
diagnostic test by naso-pharyngel swab to confirm the diagnosis of covid-19 at moderate and severe cases.
severe cases
RT PCR test of COVID 19
diagnostic test by naso-pharyngel swab to confirm the diagnosis of covid-19 at moderate and severe cases.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
RT PCR test of COVID 19
diagnostic test by naso-pharyngel swab to confirm the diagnosis of covid-19 at moderate and severe cases.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
1 Day
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hanaa Mohamed Hussien
assistant lecturer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Medicine and Surgery At Assiut Univesity
Asyut, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Diagnosis of COVID-19
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.